Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

Evidence for human leukocyte antigen heterozygote advantage against hepatitis C virus infection.

Hraber P, Kuiken C, Yusim K.

Hepatology. 2007 Dec;46(6):1713-21.

PMID:
17935228
2.

Influence of HLA haplotypes on the clinical courses of individuals infected with hepatitis C virus.

Kuzushita N, Hayashi N, Moribe T, Katayama K, Kanto T, Nakatani S, Kaneshige T, Tatsumi T, Ito A, Mochizuki K, Sasaki Y, Kasahara A, Hori M.

Hepatology. 1998 Jan;27(1):240-4.

PMID:
9425943
3.

A comparative review of HLA associations with hepatitis B and C viral infections across global populations.

Singh R, Kaul R, Kaul A, Khan K.

World J Gastroenterol. 2007 Mar 28;13(12):1770-87. Review.

4.

HLA-DR5 antigen. A genetic factor influencing the outcome of hepatitis C virus infection?

Peano G, Menardi G, Ponzetto A, Fenoglio LM.

Arch Intern Med. 1994 Dec 12-26;154(23):2733-6.

PMID:
7993158
5.

The influence of HLA alleles and HBV subgenotyes on the outcomes of HBV infections in Northeast China.

Li X, Liu W, Wang H, Jin X, Fang S, Shi Y, Liu Z, Zhang S, Yang S.

Virus Res. 2012 Jan;163(1):328-33. doi: 10.1016/j.virusres.2011.10.020.

PMID:
22056847
6.

Ethnicity and route of HCV infection can influence the associations of HLA with viral clearance in an ethnically heterogeneous population.

de Almeida BS, Silva GM, da Silva PM, Perez Rde M, Figueiredo FA, Porto LC.

J Viral Hepat. 2011 Oct;18(10):692-9. doi: 10.1111/j.1365-2893.2010.01429.x.

PMID:
21914086
7.

Association between human leukocytes antigen alleles and chronic hepatitis C virus infection in the Korean population.

Yoon SK, Han JY, Pyo CW, Yang JM, Jang JW, Kim CW, Chang UI, Bae SH, Choi JY, Chung KW, Sun HS, Choi HB, Kim TG.

Liver Int. 2005 Dec;25(6):1122-7.

PMID:
16343061
8.

HLA DRB1 alleles and hepatitis C virus infection in chronic kidney disease patients.

Shaheen NM, Soliman AR, El-Khashab SO, Hanna MO.

Ren Fail. 2013;35(3):386-90. doi: 10.3109/0886022X.2012.761038.

PMID:
23391249
9.

Association between human leukocyte antigen class I and II alleles and hepatitis C virus infection in high-risk hemodialysis patients awaiting kidney transplantation.

Grimaldi V, Sommese L, Picascia A, Casamassimi A, Cacciatore F, Renda A, De Rosa P, Montesano ML, Sabia C, Fiorito C, De Iorio G, Napoli C.

Hum Immunol. 2013 Dec;74(12):1629-32. doi: 10.1016/j.humimm.2013.08.008.

PMID:
23974050
10.

Association of HLA alleles with hepatitis C infection in Maharashtra, western India.

Tripathy AS, Shankarkumar U, Chadha MS, Ghosh K, Arankalle VA.

Indian J Med Res. 2009 Nov;130(5):550-5.

PMID:
20090103
11.

Ethnic and geographical differences in HLA associations with the outcome of hepatitis C virus infection.

Wang JH, Zheng X, Ke X, Dorak MT, Shen J, Boodram B, O'Gorman M, Beaman K, Cotler SJ, Hershow R, Rong L.

Virol J. 2009 May 1;6:46. doi: 10.1186/1743-422X-6-46.

12.

Influence of immunogenetic background on the outcome of recurrent hepatitis C after liver transplantation.

Belli LS, Zavaglia C, Alberti AB, Poli F, Rondinara G, Silini E, Taioli E, de Carlis L, Scalamogna M, Forti D, Pinzello G, Idèo G.

Hepatology. 2000 Jun;31(6):1345-50.

PMID:
10827162
13.

Association of human leukocyte antigen polymorphism with outcomes of hepatitis B virus infection.

Ramezani A, Hasanjani Roshan MR, Kalantar E, Eslamifar A, Banifazl M, Taeb J, Aghakhani A, Gachkar L, Velayati AA.

J Gastroenterol Hepatol. 2008 Nov;23(11):1716-21. doi: 10.1111/j.1440-1746.2008.05482.x.

PMID:
18761557
14.

Relation of HLA class I and II supertypes with spontaneous clearance of hepatitis C virus.

Kuniholm MH, Anastos K, Kovacs A, Gao X, Marti D, Sette A, Greenblatt RM, Peters M, Cohen MH, Minkoff H, Gange SJ, Thio CL, Young MA, Xue X, Carrington M, Strickler HD.

Genes Immun. 2013 Jul-Aug;14(5):330-5. doi: 10.1038/gene.2013.25.

15.

[Association between HLA antigens and hepatitis C virus (HCV) infection].

Nowakowska B, Kacprzak-Bergman I.

Postepy Hig Med Dosw (Online). 2004;58:458-62. Review. Polish.

16.

Effect of HLA on hepatitis C virus clearance and persistence in anti-HCV-positive end-stage renal disease patients.

Ocal S, Selcuk H, Korkmaz M, Altun R, Yildirim AE, Akbas E.

Saudi J Gastroenterol. 2014 May-Jun;20(3):175-81. doi: 10.4103/1319-3767.133007.

17.

Human leukocyte antigen phenotypes and hepatitis C viral load.

Wang LY, Lin HH, Lee TD, Wu YF, Hu CT, Cheng ML, Lo SY.

J Clin Virol. 2005 Feb;32(2):144-50.

PMID:
15653417
18.

Association between HLA class II genotype and spontaneous clearance of hepatitis C viraemia.

Cramp ME, Carucci P, Underhill J, Naoumov NV, Williams R, Donaldson PT.

J Hepatol. 1998 Aug;29(2):207-13.

PMID:
9722201
19.

Hepatitis C virus-related hepatocellular carcinoma and B-cell lymphoma patients show a different profile of major histocompatibility complex class II alleles.

De Re V, Caggiari L, Talamini R, Crovatto M, De Vita S, Mazzaro C, Cannizzaro R, Dolcetti R, Boiocchi M.

Hum Immunol. 2004 Nov;65(11):1397-404.

PMID:
15556690
20.

The association between the genetic polymorphism of HLA-DQA1, DQB1, and DRB1 and serum alanine aminotransferase levels in chronic hepatitis C in the Chinese population.

Yu RB, Hong X, Ding WL, Tan YF, Zhang YX, Sun NX, Wu GL, Zhan SW, Ge DF.

J Gastroenterol Hepatol. 2008 Sep;23(9):1394-402.

PMID:
18028350

Supplemental Content

Support Center